NOACs a better combo for PPIs than warfarin for reducing gastrointestinal bleeding risk
In patients on proton pump inhibitor (PPI) medication, co-treatment with nonvitamin K antagonist oral anticoagulants (NOACs), rather than warfarin, may be better and lead to lower risks of upper gastrointestinal bleeding and mortality, a recent study has found.
